Owlet Inc. CEOs and CFOs Offload Shares to Cover Taxes in Quiet Mid‑Market Sale

Insider Selling in a Tax‑Covering Move On January 20, 2026, Owlet Inc.’s President and CEO, Jonathan Harris, sold 2,311 shares of common stock as part of a non‑discretionary transaction to cover taxes and fees linked to the vesting of restricted stock units. The sale occurred at $13.33 per share, leaving Harris with 264,396 shares—roughly 1.2 % of the outstanding equity. Although the trade is routine and driven by tax logistics rather than a change in market outlook, the timing is noteworthy because it coincides with a broader wave of insider activity across the board.

A Quiet Surge in Company‑Wide Selling The same day, Chief Financial Officer Amanda Crawford executed a sell of 183 shares, bringing her post‑transaction holdings to 150,325. Both transactions, while modest in size relative to the company’s $378.96 million market cap, signal that senior executives are managing personal tax liabilities amid a stock price that has slipped 2.35 % in the last week and 7.78 % monthly. The overall sentiment on social platforms remains mildly positive (+50) but the buzz is unusually high at 108 %—suggesting that investors and traders are watching closely for any hint of a shift in management’s confidence.

Implications for Investors From an investor’s standpoint, the trades do not raise immediate red flags. The shares were sold at a price slightly below the market close of $13.70, implying no aggressive divestiture. However, the simultaneous activity by both the CEO and CFO may prompt analysts to probe whether the company is anticipating tighter liquidity needs or planning a significant capital‑raising event. The negative P/E of –5.89 and a declining share price trend further underscore the company’s current valuation challenges. If insiders continue to offload shares to cover taxes, it could subtly erode the stock’s liquidity and dampen investor confidence unless counterbalanced by robust product pipeline progress.

What This Means for Owlet’s Future Owlet’s core product—proactive health monitoring for infants—has shown impressive data collection, with over 1.2 million monitored infants reported in a recent announcement. Yet, the company’s financials remain negative, and its stock has retreated from the year’s high of $16.94. Insider selling driven by tax obligations does not equate to a bearish outlook, but it does highlight the pressure senior leaders face to maintain personal financial positions while steering a growth‑stage company. Going forward, investors should monitor whether subsequent filings reveal larger block sales or a shift toward equity‑based compensation plans that could better align executive incentives with long‑term shareholder value.